Population
Adults and children with dilated cardiomyopathy or anthracycline-induced cardiomyopathy
Design
Review
Authors
Loading...
Potential cardioprotective effects merit randomized trials in dilated cardiomyopathy and anthracycline recipients; does not support practice change.
This review highlights the potential cardioprotective role of carvedilol in managing dilated cardiomyopathy and mitigating anthracycline-induced cardiotoxicity.
Watanabe et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: